{"ticker": {"uuid": "1a8f5973-bcf0-446d-a2d8-6608c0260b8b", "symbol": "6622", "name": "Zhaoke Ophthalmology Limited", "exchange": "HKG", "country": "HK", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Zhaoke Ophthalmology Secures Global Rights to Pediatric Myopia Drug NVK002", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPNnI3bjNzNVljYU9oUkZxbVpKUW0xUS1Vb0FOMV82aDRsa2RGNTNWU1o4M2gzRzdMRVIwMGZkT01hYlJBMTdTeVhKdVpmbHRMNTZudFFFaWtEN0NXeWNrUnhwaUJlSGdYUHdMX0ZlVm1KcTBhLTJXeEFhX1lnNldGdU1JQzJCLWtuN1JIVWtqVmJQOVNmUzZVaTNsbkIwTFRyb1hWWGVOc29wQ1lNY0xoNGJYaWhEaVNKVmQ0WGVNR3lwd1ll?oc=5", "source_name": "TipRanks", "published_at": "2026-07-13T09:11:43+00:00", "published_display": "13 Jul 2026 09:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Visus Therapeutics, Inc., and Zhaoke Ophthalmology Limited Announce Exclusive Licensing Agreement to Commercialize BRIMOCHOL\u2122 PF and Carbachol PF in Greater China, South Korea and Select Southeast Asian Markets for the Treatment of Presbyopi", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Wire", "published_at": "2022-05-11T07:00:00+00:00", "published_display": "11 May 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Zhaoke Ophthalmology Secures Global Rights to Pediatric Myopia Drug NVK002", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPNnI3bjNzNVljYU9oUkZxbVpKUW0xUS1Vb0FOMV82aDRsa2RGNTNWU1o4M2gzRzdMRVIwMGZkT01hYlJBMTdTeVhKdVpmbHRMNTZudFFFaWtEN0NXeWNrUnhwaUJlSGdYUHdMX0ZlVm1KcTBhLTJXeEFhX1lnNldGdU1JQzJCLWtuN1JIVWtqVmJQOVNmUzZVaTNsbkIwTFRyb1hWWGVOc29wQ1lNY0xoNGJYaWhEaVNKVmQ0WGVNR3lwd1ll?oc=5", "source_name": "TipRanks", "published_at": "2026-07-13T09:11:43+00:00", "published_display": "13 Jul 2026 09:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Visus Therapeutics, Inc., and Zhaoke Ophthalmology Limited Announce Exclusive Licensing Agreement to Commercialize BRIMOCHOL\u2122 PF and Carbachol PF in Greater China, South Korea and Select Southeast Asian Markets for the Treatment of Presbyopi", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Wire", "published_at": "2022-05-11T07:00:00+00:00", "published_display": "11 May 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 79, "total_relevant": 2, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 2, "score": 50, "total": 2, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 75, "events": [{"event": "general", "label": "Market update", "weight": 1.1, "count": 2}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 2.65, "latest_week": "2026-07-10", "one_week_move": 1.5, "four_week_move": -7.3, "twelve_week_move": -15.9, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.957271, "market_dynamics_buy_signal": false, "relative_strength": -12.100301, "fair_value_gap": 4.2, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 44.0341, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+1.5% over one week, -7.3% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 56, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TipRanks", "count": 1}, {"label": "Business Wire", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 2}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "75/100 classification confidence."}, {"label": "Company focus", "value": "2", "tone": "neutral", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+1.5% over one week, -7.3% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Zhaoke Ophthalmology Secures Global Rights to Pediatric Myopia Drug NVK002"}], "updated_at": "2026-07-17T22:01:18.270125+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}